Given the rapid development of nanotechnology, regulatory guidelines are continually evolving. Agencies such as the FDA, EPA, and OECD are actively working to develop frameworks for the safe use of nanomaterials. These guidelines often focus on:
Standardizing methods for characterizing nanomaterials. Establishing protocols for toxicity testing. Developing guidelines for risk assessment and management.
